PA1

2-amino-2-deoxy-alpha-D-glucopyranose

PA1 is found in 10 entries

PA1 as free ligands, exist in 10 entries. Examples include 1FI1, 1PBR, 1QFF

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name 2-amino-2-deoxy-alpha-D-glucopyranose
Identifiers (2S,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
Formula C6 H13 N O5
Molecular Weight 179.17 g/mol
Type non-polymer
Isomeric SMILES N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
InChI InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6+/m1/s1
InChI Key MSWZFWKMSRAUBD-UKFBFLRUSA-N

Chemical Details

Formal Charge 0
Atom Count 25
Chiral Atom Count 5
Chiral Atoms C1 C2 C3 C4 C5
Bond Count 25
Aromatic Bond Count 0
Leaving Atoms O1 HO1

Drug Info: DrugBank

DrugBank ID DB01296   (Different stereochemistry)
Name Glucosamine
Groups approved
Description Glucosamine is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies. It is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis.
Synonyms
  • 2-Amino-2-deoxy-D-glucose
  • Chitosamine
  • D-Glucosamine
Salts Glucosamine sulfate
Brand Names Remaxazon External Patch
Affected Organism Humans and other mammals
Indication Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question.
Pharmacology Osteoarthritis is characterized by the progressive degeneration of cartilage glycosaminoglycans. The formation of glucosamine is the rate limiting step in glycosaminoglycans synthesis thus the addition is glucosamine, would in theory provide a building block towards the synthesis of glycosaminoglycans and thus slow down the progression of osteoarthritis. Thus far however, the results have not been conclusive.
Mechanism of action Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Oral glucosamine is commonly used for the treatment of osteoarthritis. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis. Its use as a therapy for osteoarthritis appears safe, but there is conflicting evidence as to its effectiveness with more recent studies showing limited to no clinical benefit of use. In the United States, glucosamine is not approved by the Food and Drug Administration for medical use in humans. Since glucosamine is classified as a dietary supplement, safety and formulation are solely the responsibility of the manufacturer; evidence of safety and efficacy is not required as long as it is not advertised as a treatment for a medical condition.
Route of administration topical
ATC-Code M01AX05
CAS number 3416-24-8
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682